To-Increase Acquires AX for Pharma

BioPhorum Acquires PharmaX Solutions

May 7, 2026

IT Services

BioPhorum has acquired PharmaX Solutions, a consultancy specializing in digital transformation and end-to-end digital manufacturing solutions for pharmaceutical manufacturing environments. The acquisition expands BioPhorum’s Implementation Services offering and extends its international footprint across offices in Germany, Spain, Denmark, and Switzerland.

Axcel (Alpine Investors) Acquires Accelebrate to Expand IT Training Portfolio

January 17, 2023

Education

Axcel, the Alpine Investors‑backed professional education platform, has acquired Accelebrate, an Atlanta‑based IT training company, and will integrate it with its IT training business Web Age Solutions. Accelebrate founder Steve Heckler will remain involved as an advisor while Accelebrate works with Tim Toomey, CEO of Web Age, to scale instructor‑led on‑site and online training for financial services, government, and technology clients.

Aditxt Signs Share Exchange Agreement to Acquire AiPharma Global Holdings

December 28, 2021

Healthcare Services

Aditxt (Nasdaq: ADTX) signed a share exchange agreement to acquire AiPharma Global Holdings LLC (AiPharma Global) in a two-step transaction involving an initial closing and a secondary closing, subject to conditions including regulatory, board, shareholder, and Nasdaq approvals. The deal would give Aditxt 9.5% of AiPharma at the initial closing and the remaining 90.5% at the secondary closing, with cash payments and Aditxt share issuance at each step.

Pfizer Acquires Amplyx Pharmaceuticals

April 28, 2021

Biotechnology

Pfizer Inc. acquired Amplyx Pharmaceuticals, a privately held clinical-stage biotechnology company developing the antifungal candidate fosmanogepix (APX001). The deal expands Pfizer's anti-infectives pipeline and secures Amplyx's lead and early-stage assets to advance development of novel antifungal and antiviral therapies.

Gilde Buy Out Partners and To-Increase Management Acquire To-Increase from Columbus

December 21, 2020

Cloud & SaaS

Columbus A/S agreed to divest its software subsidiary To-Increase to Gilde Buy Out Partners alongside To-Increase management for an enterprise value of EUR 113 million. The divestment is part of Columbus' strategic refocus to become a global consultancy and is expected to close in January 2021 subject to Works Council consultation; Gilde plans to support organic growth acceleration and bolt-on M&A for To-Increase.

Nicox S.A. Acquires Aciex Therapeutics, Inc.

July 2, 2014

Pharmaceuticals

Nicox S.A. agreed to acquire Aciex Therapeutics, Inc., a U.S.-based ophthalmic development company, in a share-exchange deal that will transfer 100% of Aciex to Nicox. The transaction (approved by Nicox shareholders on October 22, 2014) issues 20,627,024 new Nicox shares for Aciex equity and includes contingent value rights giving up to $55 million in potential additional consideration tied to FDA approvals, and is intended to broaden Nicox's ophthalmic development pipeline.